Pharmaceutical Analysis
July 24-25, 2006
  
 
  

Symposium Chair:

Robert K. Lantz
Rocky Mountain Instrumental Laboratories
108 Coronado Court
Fort Collins, CO 80525
Phone: 303-530-1169  Fax: 303-530-1169
e-mail: rklantz@rockylab.com

Keynote Speaker:

Brenda P. Fielding
Regulus Pharmaceutical Consulting, LLC
 
CGMP Requirements for Early Clinical Development: Implication of FDA Guidance Document.

   

 

Monday, July 24, 2006

P.L.Sulik Presiding

12:55

Opening Remarks

1:00

Understanding Karl Fischer Titration. Doug Clark, Sigma-Aldrich

4:10

On-Line Monitoring of Water Supplies with Heuristic Algorithms. A Valuable Tool for Process Control. Dan Kroll, Hach Homeland Security Technologies

5:00-7:00

Conference Reception

Tuesday, July 25, 2006

8:10

KEYNOTE SPEAKER: CGMP Requirements for Early Clinical Development: Implication of FDA Guidance Document. Brenda P. Fielding, Regulus Pharmaceutical Consulting, LLC

R.K. Lantz Presiding

9:15

Opening Remarks

9:20

Optimizing the Solution Behavior of Biopharmaceuticals - Rapid Determination of Osmotic Second Virial Coefficients by Self-interaction Chromatography. Mark Cornell Manning, Legacy BioDesign LLC; Charles S. Henry, Robert W. Payne and Joseph J. Valente, Colorado State University; W. William Wilson, Mississippi State University

9:50

Quantitation of Endogenous Purineosides in Plasma by HILIC LC-MS_MS. Martin Risk, Lane R. Bushman and Peter L. Anderson, University of Colorado Health Sciences Center

10:20

Closing Remarks

Posters

 
 
 
Click here for online registration
 
 
 
Milestone Presentations, LLC
4255 S. Buckley Rd., #118, Aurora, CO 80013
Phone: (800) 996-3233 or (303) 690-3233 | Fax: (888) 996-3296 or (303) 690-3278
 
  info@rockychem.com

Return to RMCAC index

 Go to Milestone Presentations Main Page